Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.
暂无分享,去创建一个
Christopher M Overall | C. Overall | A. Prudova | A. Doucet | G. Butler | D. Rodríguez | Anna Prudova | Georgina S. Butler | Alain Doucet | Georgina S Butler | David Rodríguez
[1] X. Puente,et al. Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.
[2] F. Melchior,et al. Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.
[3] X. Puente,et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.
[4] Marc W. Kirschner,et al. How Proteolysis Drives the Cell Cycle , 1996, Science.
[5] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[6] C. Boyault,et al. Regulation of protein turnover by acetyltransferases and deacetylases. , 2008, Biochimie.
[7] Y. Hoshida,et al. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment , 2005, Proteomics.
[8] Christopher M Overall,et al. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.
[9] Jill L. Wegrzyn,et al. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. , 2008, Annual review of pharmacology and toxicology.
[10] J. Clancy,et al. A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation12 , 2008, The Journal of Immunology.
[11] J. Whelan,et al. Processing of the dual targeted precursor protein of glutathione reductase in mitochondria and chloroplasts. , 2004, Journal of molecular biology.
[12] M. Pelto-huikko,et al. Shedding light on ADAM metalloproteinases. , 2005, Trends in biochemical sciences.
[13] S. Dower,et al. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. , 1994, Journal of immunology.
[14] Bonnie F. Sloane,et al. Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment , 2007, Molecular Cancer Research.
[15] L. Cantley,et al. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries , 2001, Nature Biotechnology.
[16] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[17] S. Stoch,et al. Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy , 2008, Clinical pharmacology and therapeutics.
[18] J. Coorssen,et al. Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis , 2005, Proteome Science.
[19] Markus Müller,et al. Quantitative Proteomic Analysis of Protein Complexes , 2008, Molecular & Cellular Proteomics.
[20] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[21] James R. Knight,et al. A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.
[22] J. Thigpen,et al. CA 15–3 and c-erbB-2 presence in the saliva of women , 1999, Clinical Oral Investigations.
[23] N. Seyfried,et al. Systematic approach for validating the ubiquitinated proteome. , 2008, Analytical chemistry.
[24] P. Griffin,et al. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. , 1994, Biochemistry.
[25] Stephen L. Sazinsky,et al. Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3 , 2007, Protein science : a publication of the Protein Society.
[26] Christopher M. Overall,et al. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer , 2006, Cancer and Metastasis Reviews.
[27] V. Hintze,et al. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains , 2007, Biological chemistry.
[28] J. Garin,et al. An Optimized Strategy for ICAT Quantification of Membrane Proteins* , 2006, Molecular & Cellular Proteomics.
[29] A. Hermetter,et al. Activity-based proteomics: enzymatic activity profiling in complex proteomes , 2006, Amino Acids.
[30] R. Beynon,et al. Positional proteomics: preparation of amino-terminal peptides as a strategy for proteome simplification and characterization , 2006, Nature Protocols.
[31] D. Bataille. Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology , 2007, Journal of Molecular Medicine.
[32] B. Sachais,et al. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. , 2007, Blood.
[33] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[34] C. López-Otín,et al. Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.
[35] H. Ploegh,et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. , 2001, Chemistry & biology.
[36] G. Plowman,et al. The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. , 1992, The Journal of biological chemistry.
[37] Y. Dong,et al. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. , 2007, Pathology, research and practice.
[38] R. Aebersold,et al. Mass Spectrometry and Protein Analysis , 2006, Science.
[39] Nasreen S Jessani,et al. Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] P. Walsh,et al. A Binding Site for Heparin in the Apple 3 Domain of Factor XI* , 1998, The Journal of Biological Chemistry.
[41] C. Overall,et al. Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis , 1999, The Journal of Biological Chemistry.
[42] J. Fox,et al. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: identification of two novel substrates with functional relevance. , 2007, Archives of biochemistry and biophysics.
[43] B. Séraphin,et al. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. , 2001, Methods.
[44] B. Cravatt,et al. Profiling serine hydrolase activities in complex proteomes. , 2001, Biochemistry.
[45] K. Sakaguchi,et al. Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth , 1998, The Journal of experimental medicine.
[46] Kim Ys,et al. Human protein digestion and absorption: normal mechanisms and protein-energy malnutrition. , 1983 .
[47] Robert Huber,et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity , 2003, Nature Structural Biology.
[48] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[49] K. Terpe. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems , 2002, Applied Microbiology and Biotechnology.
[50] K. Ishii,et al. Processing and Functions of Hepatitis C Virus Proteins , 1999, Intervirology.
[51] B. Séraphin,et al. A generic protein purification method for protein complex characterization and proteome exploration , 1999, Nature Biotechnology.
[52] Guanghui Wang,et al. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of Proteome Research.
[53] M. Haine,et al. Van Damme A. , 1986 .
[54] C. Overall,et al. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.
[55] A. Burlingame,et al. Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.
[56] J. Gordon,et al. Proteolytic processing and compartmentalization of the primary translation products of mammalian apolipoprotein mRNAs. , 1986, CRC critical reviews in biochemistry.
[57] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[58] P. Vandenabeele,et al. Caspase-containing complexes in the regulation of cell death and inflammation , 2006, Biological chemistry.
[59] K. Gevaert,et al. Improved recovery of proteome‐informative, protein N‐terminal peptides by combined fractional diagonal chromatography (COFRADIC) , 2008, Proteomics.
[60] R. Ozawa,et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Wiseman,et al. Determination of enzyme specificity in a complex mixture of peptide substrates by N-terminal sequence analysis. , 1991, Analytical biochemistry.
[62] M. MacCoss,et al. Quantitative Profiling of Ubiquitylated Proteins Reveals Proteasome Substrates and the Substrate Repertoire Influenced by the Rpn10 Receptor Pathway*S , 2007, Molecular & Cellular Proteomics.
[63] C. Vanpouille,et al. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[64] Darius Moradpour,et al. Structural biology of hepatitis C virus. , 2003, Clinics in liver disease.
[65] A. Barrett. Bioinformatics of proteases in the MEROPS database. , 2004, Current opinion in drug discovery & development.
[66] A. Bauch,et al. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells , 2006, Nature Methods.
[67] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[68] Z. Darżynkiewicz,et al. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors. , 2002, Experimental hematology.
[69] R. Baserga,et al. A modified tandem affinity purification tag technique for the purification of protein complexes in mammalian cells , 2005, Proteomics.
[70] K. Suzuki,et al. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.
[71] W. Stetler-Stevenson,et al. Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. , 2004, The Biochemical journal.
[72] V. Cryns,et al. Proteases to die for. , 1998, Genes & development.
[73] M. Parmentier,et al. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. , 2007, Blood.
[74] T. Peretz,et al. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival , 2007, British Journal of Cancer.
[75] H. Ragab,et al. Soluble cytokeratin-19 and E-selectin biomarkers: their relevance for lung cancer detection when tested independently or in combinations. , 2008, Cancer biomarkers : section A of Disease markers.
[76] T. Rapoport,et al. A signal sequence receptor in the endoplasmic reticulum membrane , 1987, Nature.
[77] E. Raines,et al. Emerging roles for ectodomain shedding in the regulation of inflammatory responses , 2006, Journal of leukocyte biology.
[78] R. Aebersold,et al. Identification of Putative Androgen Receptor Interaction Protein Modules , 2007, Molecular & Cellular Proteomics.
[79] K. Downard,et al. Ions of the interactome: The role of MS in the study of protein interactions in proteomics and structural biology , 2006, Proteomics.
[80] G. Dubin,et al. Proteinaceous cysteine protease inhibitors , 2005, Cellular and Molecular Life Sciences.
[81] Jeffrey W. Smith,et al. Profiling constitutive proteolytic events in vivo. , 2007, The Biochemical journal.
[82] N. D. Da Silva,et al. Sequential cloned gene integration in the yeast Kluyveromyces lactis , 2003, Applied Microbiology and Biotechnology.
[83] H. Ploegh,et al. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. , 2002, Current opinion in immunology.
[84] B. Wiederanders,et al. Functions of propeptide parts in cysteine proteases. , 2003, Current protein & peptide science.
[85] Thierry Meinnel,et al. The Proteomics of N-terminal Methionine Cleavage*S , 2006, Molecular & Cellular Proteomics.
[86] B. Fingleton. Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects , 2003, Expert opinion on therapeutic targets.
[87] Wei Wang,et al. Identification of Novel Protein-Protein Interactions Using A Versatile Mammalian Tandem Affinity Purification Expression System* , 2003, Molecular & Cellular Proteomics.
[88] P. Young,et al. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[89] R. Crystal,et al. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. , 1981, Science.
[90] S. H. Baek,et al. Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.
[91] C. Overall,et al. Towards third generation matrix metalloproteinase inhibitors for cancer therapy , 2006, British Journal of Cancer.
[92] R. Campbell,et al. Homodimerization of calpain 3 penta-EF-hand domain. , 2005, The Biochemical journal.
[93] C. Craik,et al. MT-SP1 proteolysis and regulation of cell-microenvironment interactions. , 2008, Frontiers in bioscience : a journal and virtual library.
[94] B. Vallee,et al. Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.
[95] C. Overall,et al. The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin Binding , 1997, The Journal of Biological Chemistry.
[96] Ruedi Aebersold,et al. The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.
[97] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[98] R. Huber,et al. Structural basis of the endoproteinase-protein inhibitor interaction. , 2000, Biochimica et biophysica acta.
[99] D. Picard. Hsp90 invades the outside , 2004, Nature Cell Biology.
[100] Gary Walsh,et al. Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.
[101] N. Thornberry,et al. A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). , 1997, Chemistry & biology.
[102] Francesco Leonetti,et al. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin , 2000, Nature Biotechnology.
[103] N. Ridgway,et al. Caspase Processing and Nuclear Export of CTP:Phosphocholine Cytidylyltransferase α during Farnesol-Induced Apoptosis , 2002, Molecular and Cellular Biology.
[104] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[105] Matthias Mann,et al. Innovations: Functional and quantitative proteomics using SILAC , 2006, Nature Reviews Molecular Cell Biology.
[106] M. Mann,et al. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.
[107] T. Köcher,et al. An efficient protein complex purification method for functional proteomics in higher eukaryotes , 2003, Nature Biotechnology.
[108] M. Ryan,et al. Translating the message. , 2001, Biologist.
[109] P. Heinrich,et al. Control of proteolysis. , 1980, Annual review of biochemistry.
[110] S. M. Park,et al. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. , 2004, Biochimica et biophysica acta.
[111] M. Mann,et al. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.
[112] C. Ioannou,et al. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. , 1993, European journal of biochemistry.
[113] Zhiheng He,et al. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis , 2003, Journal of Molecular Medicine.
[114] J. Wallace,et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.
[115] Zbynek Bozdech,et al. Biochemical Analysis of the 20 S Proteasome of Trypanosoma brucei * , 2003, The Journal of Biological Chemistry.
[116] L. Tarassishin,et al. Stereoselective Synthesis of Photoreactive Peptidomimetic γ-Secretase Inhibitors , 2004 .
[117] Gillian Murphy,et al. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.
[118] Vincent Collura,et al. From protein-protein complexes to interactomics. , 2007, Sub-cellular biochemistry.
[119] J. Baselga,et al. Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis , 2006, Molecular and Cellular Biology.
[120] R. Beynon,et al. Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides , 2005, Nature Methods.
[121] M. Mann,et al. Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) , 2006, Nature Methods.
[122] K. Gevaert,et al. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis , 2005, Nature Methods.
[123] A. R. Khan,et al. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes , 1998, Protein science : a publication of the Protein Society.
[124] J. Thigpen,et al. A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma , 2000, Cancer investigation.
[125] R. Aebersold,et al. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics , 2004, Nature Structural &Molecular Biology.
[126] E. Wolf,et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.
[127] J. Wells,et al. Substrate phage: selection of protease substrates by monovalent phage display. , 1993, Science.
[128] P. Bork,et al. Proteome survey reveals modularity of the yeast cell machinery , 2006, Nature.
[129] H. Meisel. Multifunctional peptides encrypted in milk proteins , 2004, BioFactors.
[130] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[131] G. Salvesen,et al. Identification of proteolytic cleavage sites by quantitative proteomics. , 2007, Journal of proteome research.
[132] J. Hutton,et al. Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases , 1994, Diabetologia.
[133] M. Mann,et al. Analysis of proteins and proteomes by mass spectrometry. , 2001, Annual review of biochemistry.
[134] J. Daurès,et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[135] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[136] S. Chattopadhaya,et al. Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. , 2004, Journal of the American Chemical Society.
[137] D. Edwards,et al. The ADAMTS metalloproteinases. , 2005, The Biochemical journal.
[138] Randy J. Read,et al. Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.
[139] T. Ley,et al. A proteomic approach for the discovery of protease substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[140] Christine Gaboriaud,et al. X-ray Structure of the Ca2+-binding Interaction Domain of C1s , 2003, Journal of Biological Chemistry.
[141] C. Overall,et al. Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP) , 2004, Journal of Biological Chemistry.
[142] C. Overall,et al. Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding , 2008, Molecular and Cellular Biology.
[143] Christopher M. Overall,et al. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.
[144] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[145] J. Beckmann,et al. Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice , 2006, Proteomics.
[146] F. Sherman,et al. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. , 2003, Journal of molecular biology.
[147] S. Jentsch,et al. Membrane-bound transcription factors: regulated release by RIP or RUP. , 2001, Current opinion in cell biology.
[148] Oliver Schilling,et al. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites , 2008, Nature Biotechnology.
[149] J. Kirsch,et al. A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[150] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[151] C. Overall,et al. Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co , 2007, Molecular and Cellular Biology.
[152] P. Cohen,et al. The origins of protein phosphorylation , 2002, Nature Cell Biology.
[153] X. Puente,et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. , 2008, Cancer research.
[154] S. Levine,et al. Mechanisms of Soluble Cytokine Receptor Generation , 2004, The Journal of Immunology.
[155] B. Cauwe,et al. The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.
[156] J. Rine,et al. Modulation of Ras and a-Factor Function by Carboxyl-Terminal Proteolysis , 1997, Science.
[157] B. Cravatt,et al. Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[158] S. Higashiyama,et al. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. , 2005, Biochimica et biophysica acta.
[159] A. Burlingame,et al. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.
[160] Y. Bourbonnais,et al. Anti-inflammatory activity of neutrophil elastase inhibitors. , 2003, Current opinion in investigational drugs.
[161] J. Riordan,et al. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. , 1991, Biochemistry.
[162] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[163] Carlos López-Otín,et al. Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.
[164] C. Overall. Molecular determinants of metalloproteinase substrate specificity , 2002, Molecular biotechnology.
[165] F. De Ceuninck,et al. High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases: possible role as a proinflammatory mediator in arthritis. , 2003, Arthritis and rheumatism.
[166] S. Zucker,et al. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.
[167] Wei Li,et al. Extracellular heat shock protein‐90α: linking hypoxia to skin cell motility and wound healing , 2007, The EMBO journal.
[168] P. Bork,et al. Functional organization of the yeast proteome by systematic analysis of protein complexes , 2002, Nature.
[169] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[170] P. Reinemer,et al. The metzincins — Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc‐peptidases , 1995, Protein science : a publication of the Protein Society.
[171] A. Ciechanover. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. , 2006, Experimental biology and medicine.
[172] J. White. ADAMs: modulators of cell-cell and cell-matrix interactions. , 2003, Current opinion in cell biology.
[173] T. Renné,et al. Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein , 1996, The Journal of Biological Chemistry.
[174] C. Overall,et al. Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry. , 2007, Current pharmaceutical design.
[175] M. Rincón,et al. Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1 , 2008, The Journal of Immunology.
[176] P. Vandenabeele,et al. Proteome-wide Identification of HtrA2/Omi Substrates. , 2007, Journal of proteome research.
[177] Alexey I Nesvizhskii,et al. Analysis and validation of proteomic data generated by tandem mass spectrometry , 2007, Nature Methods.
[178] Gary D Bader,et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.
[179] K. Mann,et al. Zymogen/enzyme discrimination using peptide chloromethyl ketones. , 1989, The Journal of biological chemistry.
[180] C. López-Otín,et al. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.
[181] Christopher M Overall,et al. Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.
[182] M. Stack,et al. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[183] P. Hasselgren,et al. Catabolic response to stress and potential benefits of nutrition support. , 2002, Nutrition.
[184] Lan Huang,et al. An Integrated Mass Spectrometry-based Proteomic Approach , 2006, Molecular & Cellular Proteomics.
[185] L. Foster,et al. Cell-based identification of natural substrates and cleavage sites for extracellular proteases by SILAC proteomics. , 2009, Methods in molecular biology.
[186] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[187] R. Huber,et al. Natural protein proteinase inhibitors and their interaction with proteinases. , 1992, European journal of biochemistry.
[188] F. Colland,et al. Targeting ubiquitin specific proteases for drug discovery. , 2008, Biochimie.
[189] William C. Parks,et al. Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.
[190] R. Aebersold,et al. A uniform proteomics MS/MS analysis platform utilizing open XML file formats , 2005, Molecular systems biology.
[191] R. Aebersold,et al. Analysis of protein complexes using mass spectrometry , 2007, Nature Reviews Molecular Cell Biology.
[192] C. Craik,et al. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[193] K. Entian,et al. Carbon Source-dependent Assembly of the Snf1p Kinase Complex in Candida albicans* , 2005, Journal of Biological Chemistry.
[194] K. Gevaert,et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.
[195] K. Brew,et al. Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.
[196] C. Overall,et al. The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation* , 1998, The Journal of Biological Chemistry.
[197] Hyojin Cho,et al. Additional MDA‐MB‐231 breast cancer cell matrix metalloproteinases promote invasiveness , 2008, Journal of cellular physiology.
[198] Christopher M. Overall,et al. In search of partners: linking extracellular proteases to substrates , 2007, Nature Reviews Molecular Cell Biology.
[199] Juergen Kast,et al. Identification of protein‐protein interactions using in vivo cross‐linking and mass spectrometry , 2004, Proteomics.
[200] C. Overall,et al. Stromal cell‐derived factors 1α and 1β, inflammatory protein‐10 and interferon‐inducible T cell chemo‐attractant are novel substrates of dipeptidyl peptidase 8 , 2008, FEBS letters.
[201] C. Hashimoto,et al. Signal transduction by a protease cascade. , 1999, Trends in cell biology.
[202] Z. Werb,et al. Proteomic Identification of In Vivo Substrates for Matrix Metalloproteinases 2 and 9 Reveals a Mechanism for Resolution of Inflammation1 , 2006, The Journal of Immunology.
[203] B. Turk. Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.
[204] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[205] C. Overall,et al. Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.